Also trades as: BDMS-R.BK (SET) · $vol 41M · BDMS.BK (SET) · $vol 40M · BDUUY (OTC) · $vol 0M · BDULF (OTC) · $vol 0M
BDUUF OTC
Bangkok Dusit Medical Services Public Company Limited
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +8.5%
1Y: +8.5%
3Y: +127.1%
$0.64
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Income Trends
Revenue
$111.4B
+3.3% ▲
5Y CAGR: +10.4%
Gross Profit
$38.9B
-2.3% ▼
5Y CAGR: +12.4%
Operating Income
$18.4B
-10.1% ▼
5Y CAGR: +11.0%
Net Income
$15.8B
-0.9% ▼
5Y CAGR: +17.0%
EPS (Diluted)
$1.00
-1.0% ▼
5Y CAGR: +17.3%
EBITDA
$25.3B
-6.0% ▼
5Y CAGR: +7.4%
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $74.5B | $91.9B | $100.9B | $107.9B | $111.4B |
| YoY Growth | +9.4% | +23.5% | +9.7% | +7.0% | +3.3% |
| Cost of Revenue | $49.5B | $58.3B | $63.4B | $68.1B | $72.5B |
| Gross Profit | $25.0B | $33.6B | $37.4B | $39.8B | $38.9B |
| Gross Margin | 33.6% | 36.6% | 37.1% | 36.9% | 34.9% |
| R&D Expenses | $0 | $0 | $0 | $0 | $0 |
| SG&A Expenses | $15.0B | $17.7B | $19.8B | $20.8B | $20.4B |
| Operating Expenses | $13.8B | $16.6B | $18.5B | $19.3B | $20.4B |
| Operating Income | $11.2B | $17.0B | $18.9B | $20.5B | $18.4B |
| Operating Margin | 15.1% | 18.5% | 18.8% | 19.0% | 16.6% |
| Interest Expense | $728M | $632M | $547M | $433M | $356M |
| Income Before Tax | $10.6B | $16.5B | $18.7B | $20.3B | $20.0B |
| Tax Expense | $2.1B | $3.2B | $3.8B | $3.8B | $3.7B |
| Net Income | $7.9B | $12.6B | $14.4B | $16.0B | $15.8B |
| Net Margin | 10.7% | 13.7% | 14.3% | 14.8% | 14.2% |
| EPS (Diluted) | $0.50 | $0.79 | $0.90 | $1.01 | $1.00 |
| EBITDA | $17.6B | $23.1B | $25.0B | $26.9B | $25.3B |
| Shares Outstanding | 15.89B | 15.89B | 15.89B | 15.89B | 15.89B |